Clinical Trials · NCT02773381
A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 15
- Start date
- Jun 2016
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Area under the serum glucose concentration-time curve